VEGF-c expression in an in vivo model of orthotopic endometrial cancer and retroperitoneal lymph node metastasis

Reproductive Biology and Endocrinology

Volumn 11, Issue 1, 2013, Pages

  Huang, Yong Wen ^a   Xu, Li Qun ^a   Luo, Rong Zhen ^a   Huang, Xin ^a   Hou, Teng ^a   Zhang, Yan Na ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Animal; Disease animal model; Endometrial cancer; Fluorescence real time quantitative PCR; Rabbit; Vascular endothelial growth factor c

Indexed keywords

MESSENGER RNA; VASCULOTROPIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; FLUORESCENCE ANALYSIS; HISTOPATHOLOGY; IN VIVO STUDY; INOCULATION; LEUKOCYTE COUNT; LYMPH NODE METASTASIS; MYOMETRIUM; NONHUMAN; PARAAORTIC LYMPH NODE; PROTEIN EXPRESSION; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; RETROPERITONEAL CANCER; RETROPERITONEAL LYMPH NODE METASTASIS; ANIMAL; BIOSYNTHESIS; CANCER TRANSPLANTATION; ENDOMETRIUM TUMOR; HUMAN; LEUKOCYTE; LYMPH NODE; METABOLISM; PATHOLOGY; RETROPERITONEUM; TUMOR CELL LINE;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

ANIMALS; CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LEUKOCYTES; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM TRANSPLANTATION; RABBITS; RETROPERITONEAL SPACE; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84877909957     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-11-49     Document Type: Article

References (27)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300. 10.3322/caac.20073, 20610543.
2. Irvin WP, Rice LW, Berkowitz RS. Advances in the management of endometrial adenocarcinoma. J Rep rod Med 2002, 47:173-189.
3. Havrilesky LJ, Cragun MJ, Calingaert B, Synan I, Secord AA, Soper JT, Clarke-Pearson DL, Berchuck A. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol 2005, 99:689-695. 10.1016/j.ygyno.2005.07.014, 16126261.
4. Nomura H, Aoki D, Suzuki N, Susumu N, Suzuki A, Tamada Y, Kataoka F, Higashiguchi A, Ezawa S, Nozawa S. Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancer. Int J Gynecol Cancer 2006, 16:799-804. 10.1111/j.1525-1438.2006.00529.x, 16681764.
5. Ueda M, Terai Y, Kumagai K, Ueki K, Yamaguchi H, Akise D, Ueki M. Vascular endothelial growth factor C gene expression is closely related to invasion phenotype in gynecological tumor cells. Gynecol Oncol 2001, 82:162-166. 10.1006/gyno.2001.6229, 11426979.
6. Achen MG, Stacker SA. Tumor lymphangiogenesis and metastatic spread-new players begin to emerge. Int J Cancer 2006, 119:1755-1760. 10.1002/ijc.21899, 16557570.
7. Roy H, Bhardwaj S, Ylä-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 2006, 580:2879-2887. 10.1016/j.febslet.2006.03.087, 16631753.
8. Takahashi K, Saga Y, Mizukami H, Takei Y, Urabe M, Kume A, Suzuki M, Ozawa K. Development of a mouse model for lymph node metastasis with endometrial cancer. Cancer Sci 2011, 102:2272-2277. 10.1111/j.1349-7006.2011.02099.x, 21910784.
9. Dobrzycka B, Terlikowski SJ, Kowalczuk O, Kulikowski M, Niklinski J. Serum levels of VEGF and VEGF-C in patients with endometrial cancer. Eur Cytokine Netw 2011, 22:45-51.
10. Kimura Y, Watanabe M, Ohga T, Saeki H, Kakeji Y, Baba H, Maehara Y. Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma. Oncol Rep 2003, 10:1747-1751.
11. Mathur SP, Mathur RS, Gray EA, Lane D, Underwood PG, Kohler M, Creasman WT. Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected]. Gynecol Oncol 2005, 98:467-483. 10.1016/j.ygyno.2005.05.003, 15982726.
12. Kawakami M, Furuhata T, Kimura Y, Yamaguchi K, Hata F, Sasaki K, Hirata K. Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer. Surgery 2003, 133:300-308. 10.1067/msy.2003.45, 12660643.
13. Kidd JG, Rous P. A transplantable rabbit carcinoma originating in a virus induced papilloma and containing the virus in masked or altered form. J Exp Med 1940, 71:813-838. 10.1084/jem.71.6.813, 2135106, 19871000.
14. Chang S, Gu M, Wu F. Establishment of transplanted endometrial neoplasm model in rabbit and its biological features. Prog Obstet Gynecol 2000, 9:163-165.
15. Duan G, Xu YK, Duan P. Establishment of a rabbit model bearing transplanted endometrial carcinoma and magnetic resonance imaging features of the metastatic lymph nodes. J South Med Univ 2008, 28:1716-1719.
16. Chen JH, Yao Q, Wang L. Establishment of VX2 breast carcinoma model in rabbit by injecting tumor mass suspension. J Med Colleges PLA 2004, 19:161-163.
17. Saintigny P, Coulon S, Kambouehner M, Ricci S, Martinot E, Danel C, Breau JL, Bernaudin JF. Realtime RT-PCR detection of CK 19, CK7 and MUCI mRNA for diagnosis of lymph node micrometastases in non-small cell lung carcinoma. Int J Cancer 2005, 115:777-782. 10.1002/ijc.20942, 15729695.
18. Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct 2001, 26:25-35. 10.1247/csf.26.25, 11345501.
19. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996, 15:290-298. 449944, 8617204.
20. Amioka T, Kitadai Y, Tanaka S, Haruma K, Yoshihara M, Yasui W, Chayama K. Vascular endothelial growth factor C expression predicts Lymph node metastasis of human gastric carcinomas invading the submucosa. Eur J Cancer 2002, 38:1413-1419. 10.1016/S0959-8049(02)00106-5, 12091074.
21. Straume O, Jackson DG, Akslen LA. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 2003, 9:250-256.
22. Ozuysal S, Bilgin T, Ozan H, Kara HF, Oztürk H, Ercan I. Angiogenesis in endometrial carcinoma:correlation with survival and clinicopathologic risk factors. Gynecol Obstet Invest 2003, 55:173-177. 10.1159/000071533, 12865598.
23. Verma NK, Dey CS. RNA-mediated gene silencing: mechanisms and its therapeutic applications. J Clin Pharm Ther 2004, 29:395-404. 10.1111/j.1365-2710.2004.00579.x, 15482382.
24. Donoghue JF, Lederman FL, Susil BJ, Rogers PA. Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma. Hum Reprod 2007, 22:1705-1713. 10.1093/humrep/dem037, 17347164.
25. Cao R, Ji H, Feng N, Zhang Y, Yang X, Andersson P, Sun Y, Tritsaris K, Hansen AJ, Dissing S, Cao Y. Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis. Proc Natl Acad Sci USA 2012, 109:15894-15899. 10.1073/pnas.1208324109, 3465417, 22967508.
26. Xie LX, Zhai TT, Yang LP, Yang E, Zhang XH, Chen JY, Zhang H. Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma. Int J Exp Pathol 2013, 94:39-46. 10.1111/iep.12005, 23317352.
27. Tamum M, Ohta Y. Serum vascular endothelial growth factor C level in patients with primary non-small cell lung carcinoma:a possible diagnostic tool for lymph node metastasis. Cancer 2003, 98:1217-1222. 10.1002/cncr.11529, 12973845.